» Articles » PMID: 37038162

Temporal Transcriptome Highlights the Involvement of Cytokine/JAK/STAT3 Signaling Pathway in the Osteoinduction of BMSCs

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2023 Apr 10
PMID 37038162
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mesenchymal stem cells (MSCs)-based therapy offers an effective strategy for bone regeneration to solve the clinical orthopedic problems. However, the transcriptional regulation of multiple transitional stages of continuous osteogenesis from MSCs has not been fully characterized.

Methods: Bone marrow mesenchymal stem cells (BMSCs) stimulated with osteogenic induction media were utilized to construct the in vitro osteogenic differentiation model. BMSCs were harvested after induction for 0, 7, 14 and 21 days, respectively, to perform the mRNA-sequencing (mRNA-Seq). The transcription factor networks and common molecules during the osteogenesis were revealed by using the temporal transcriptome. Further verification was performed by the quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence and Western blotting.

Results: It showed that BMSCs could differentiate into osteogenic, and crucial regulator in the MAPK signaling pathway, the PPAR signaling pathway, the Toll-like receptor signaling and the Cytokine/JAK/STAT signaling pathway. PPI protein interaction analysis also suggested that three cytokines are involved in osteogenic differentiation as core genes, including leukemia inhibitory factor (LIF), interleukin-6 (IL6) and colony-stimulating factor 3 (CSF3). The osteogenic process was negatively affected by the inhibition of JAK/STAT3 signaling pathway.

Conclusions: This work might provide new insights in the crucial features of the transcriptional regulation during the osteogenesis, as well as offer important clues about the activity and regulation of the relatively long-activated Cytokine/JAK/STAT3 signaling pathway in osteoinduction of BMSCs.

References
1.
Huang R, Sun Y, Ho C, Liu K, Tang Q, Xie Y . IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways. Cell Death Dis. 2018; 9(2):144. PMC: 5833364. DOI: 10.1038/s41419-017-0126-0. View

2.
Natarajan D, Ye Z, Wang L, Ge L, Pathak J . Rare earth smart nanomaterials for bone tissue engineering and implantology: Advances, challenges, and prospects. Bioeng Transl Med. 2022; 7(1):e10262. PMC: 8780931. DOI: 10.1002/btm2.10262. View

3.
Murphy M, Moncivais K, Caplan A . Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013; 45:e54. PMC: 3849579. DOI: 10.1038/emm.2013.94. View

4.
Coates B, McKenzie J, Yoneda S, Silva M . Interleukin-6 (IL-6) deficiency enhances intramembranous osteogenesis following stress fracture in mice. Bone. 2020; 143:115737. PMC: 8408837. DOI: 10.1016/j.bone.2020.115737. View

5.
Zhang H, Coblentz C, Watanabe-Smith K, Means S, Means J, Maxson J . Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation. J Biol Chem. 2018; 293(19):7387-7396. PMC: 5950016. DOI: 10.1074/jbc.RA118.002417. View